Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors?
Author:
- The Optimising the Analysis of Stroke Trials (OAST) CollaborationTCThe Optimising the Analysis of Stroke Trials (OAST) Collaboration
- 1 March 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 40 (3) , 888-894
Abstract
Background and Purpose— Many stroke trials have provided neutral results. Suboptimal statistical analyses may be failing to detect effective interventions. Adjusting outcomes for baseline prognostic factors in the analysis may improve the efficiency of analysis of outcomes. Methods— Data from 23 stroke trials (25 674 patients) assessing functional outcome were included. The prognostic variables considered were age, sex, and baseline severity. Unadjusted and adjusted ordinal logistic regression models were compared using simulated data from each trial (10 000 simulations per trial). Three levels of treatment effect were assessed with ORs of 0.95, 0.74, and 0.57. The reduction in sample size gained from using the adjusted models, as compared with an unadjusted model, was then calculated as a reflection of the increase in statistical power. Results— Adjusting outcome for baseline factors led to a reduction in sample size, which was similar across all 3 treatment effects (median percentage reduction, interquartile range): OR=0.95: 35.3% (21.0 to 42.1); OR=0.74: 38.4% (29.4 to 42.7); and OR=0.57: 38.4% (27.4 to 42.2). As the treatment effect increased, the proportion of simulations in which the treatment effect for the adjusted model was greater than for the unadjusted model also increased. Conclusion— Adjusting for prognostic factors in stroke trials can reduce sample size by at least 20% to 30% (the lower interquartile range) for a given power. Conversely, trialists may want to power for an unadjusted analysis and then increase statistical power by adjusting for prognostic factors.Keywords
This publication has 31 references indexed in Scilit:
- Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY)Stroke, 2007
- The Virtual International Stroke Trials ArchiveStroke, 2007
- Can We Improve the Statistical Analysis of Stroke Trials?Stroke, 2007
- Adjustment for Strong Predictors of Outcome in Traumatic Brain Injury Trials: 25% Reduction in Sample Size Requirements in the IMPACT StudyJournal of Neurotrauma, 2006
- Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic StrokeStroke, 2005
- Age and National Institutes of Health Stroke Scale Score Within 6 Hours After Onset Are Accurate Predictors of Outcome After Cerebral IschemiaStroke, 2004
- Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trialStatistics in Medicine, 2003
- Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problemsStatistics in Medicine, 2002
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995